推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Blood Advances 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
Wiley 2026暑期线上学习营 | 报名正式开启!
多本ABS四星!优质经管国际期刊列表
Springer Nature生物医学与生命科学资源合集 | 附免费书单

按研究方向查看:


Blood Advances期刊基本信息Hello,您是该期刊的第38967位访客


基本信息 登录收藏
期刊名字Blood AdvancesBlood Advances

BLOOD ADV
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.2
53人评分
我要评分

声誉
8.8

影响力
6.1

速度
7.0

期刊ISSN2473-9529
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN2473-9537
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:7.6
2025-2026自引率3.9%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
7.398数据由网友[钢琴3672]收集提供
h-index 暂无h-index数据
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
11.803.1101.750
学科分区排名百分位
大类:Medicine
小类:Hematology
Q113 / 151

期刊简介
Blood Advances is a semimonthly medical journal published by the American Society of Hematology. It is the first journal to join the Blood family in 70 years and is a peer-reviewed, online only, open access journal. Under the direction of founding editor-in-chief Robert Negrin, MD, Stanford University Medical Center, Stanford, CA, the inaugural issue debuted on November 29, 2016.

Blood Advances provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer-review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation.
期刊官方网站https://www.journals.elsevier.com/blood-advances
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址
该期刊中国学者近期发文 - NewBCMA/CD19 dual-targeting CAR T-cell therapy in older patients with newly diagnosed multiple myeloma: a phase 1 study
Author: Liu, Jin; Fan, Xiaoqiang; Peng, Liying; Liu, Jia; He, Haiyan; Qiang, Wanting; Jin, Lina; Shi, Lang; Lu, Jing; Guo, Pei; Shah, Nina; Zhang, Qi; Shen, Lianjun; Du, Juan
Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 12, pp. 4134-4143. DOI: 10.1182/bloodadvances.2025019036


Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First
Author: Levis, Mark J.; Erba, Harry P.; Montesinos, Pau; Patkowska, Elzbieta; Cortes, Jorge; Perl, Alexander E.; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F.; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Laadem, Abderrahmane; Burns, Kristy; Sekeres, Mikkael A
Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 12, pp. 4144-4159. DOI: 10.1182/bloodadvances.2025017738


Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma (vol 9, pg 3249, 2025)
Author: Zhang, Bo
Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3832-3832. DOI: 10.1182/bloodadvances.2026020555


Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction
Author: Gill, Harinder; Au, Lester; Yim, Rita; Lee, Paul; Li, Vivian; Chin, Lynn; Zhang, Qi; Chan, Po-Yan; Lee, Carmen Y. Y.; Wu, Tony K. Y.; Leung, Garret M. K.; Kwong, Yok-Lam
Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3920-3930. DOI: 10.1182/bloodadvances.2026019612


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Blood Advances的语言要求,还能让Blood Advances编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Blood Advances编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式2021 L ST NW, SUITE 900, WASHINGTON, USA, DC, 20036
出版商American Society of Hematology
涉及的研究方向Medicine-Hematology
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 494点击查看年文章数趋势图
Gold OA文章占比99.75%
研究类文章占比:
文章 ÷(文章 + 综述)
94.94%
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
HEMATOLOGY
血液学
2区2区2区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
HEMATOLOGY
血液学
1区4区2区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
HEMATOLOGY
血液学
1区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
中科院的全球OA期刊索引(OAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2473-9529%5BISSN%5D
平均审稿速度网友分享经验:

平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Blood Advances顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 Blood Advances期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Blood Advances期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Blood Advances上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of the National Cancer Center031.20
    HemaSphere06.90
    Transplantation and Cellular Therapy08.10
    Clinical Lymphoma Myeloma & Leukemia02.60
    Current Hematologic Malignancy Reports286.60
    Hematology-American Society of Hematology Education Program835.10
    Blood Science04.20
    Research and Practice in Thrombosis and Haemostasis04.70
    Thrombosis Journal03.80
    Mediterranean Journal of Hematology and Infectious Diseases233.20
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE909923
    JOURNAL OF ETHNOPHARMACOLOGY812257
    Frontiers in Immunology759685
    BIOMEDICINE & PHARMACOTHERAPY733222
    Frontiers in Pharmacology726228
    BIOMATERIALS722292
    PHYTOMEDICINE655037
    Frontiers in Oncology627944
    Biomedical Signal Processing and Control612535
    IEEE Journal of Biomedical and Health Informatics607332
  •  

    Blood Advances Blood Advances
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.BCMA/CD19 dual-targeting CAR T-cell therapy in older patients with newly diagnosed multiple myeloma: a phase 1 study

    Author: Liu, Jin; Fan, Xiaoqiang; Peng, Liying; Liu, Jia; He, Haiyan; Qiang, Wanting; Jin, Lina; Shi, Lang; Lu, Jing; Guo, Pei; Shah, Nina; Zhang, Qi; Shen, Lianjun; Du, Juan
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 12, pp. 4134-4143. DOI: 10.1182/bloodadvances.2025019036
        PubMed      DOI
    2.Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First

    Author: Levis, Mark J.; Erba, Harry P.; Montesinos, Pau; Patkowska, Elzbieta; Cortes, Jorge; Perl, Alexander E.; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F.; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Laadem, Abderrahmane; Burns, Kristy; Sekeres, Mikkael A
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 12, pp. 4144-4159. DOI: 10.1182/bloodadvances.2025017738
        PubMed      DOI
    3.Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma (vol 9, pg 3249, 2025)

    Author: Zhang, Bo
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3832-3832. DOI: 10.1182/bloodadvances.2026020555
        DOI
    4.Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction

    Author: Gill, Harinder; Au, Lester; Yim, Rita; Lee, Paul; Li, Vivian; Chin, Lynn; Zhang, Qi; Chan, Po-Yan; Lee, Carmen Y. Y.; Wu, Tony K. Y.; Leung, Garret M. K.; Kwong, Yok-Lam
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3920-3930. DOI: 10.1182/bloodadvances.2026019612
        PubMed      DOI
    5.MSLN expression predicts a high risk of EMD in AML by promoting cell adhesion and metastasis via interaction with MUC16

    Author: Wang, Lan; Zhan, Qian; Luo, Jing; Li, Ju; He, Chaocan; Zhu, Yan; Pei, Caixia; Chen, Yuting; Tang, Na-Na; Yin, Jiaxiu; Su, Li; Chen, Jiaojiao; Xie, Mingling; Liu, Lin; Luo, Xiao-Hua
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3878-3896. DOI: 10.1182/bloodadvances.2025017325
        PubMed      DOI
    6.Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma

    Author: Xie, Zucheng; Qin, Yan; Xue, Xuemin; Chen, Xinrui; Xie, Tongji; Zhu, Haohua; Huang, Liling; Yang, Sheng; Yang, Jianliang; Liu, Peng; Gui, Lin; Tang, Le; Feng, Xiaoli; Shi, Yuankai
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3966-3982. DOI: 10.1182/bloodadvances.2025018014
        PubMed      DOI
    7.Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma

    Author: Song, Zheng; Cheng, Ying; Yang, Haiyan; Zhang, Liling; Zou, Liqun; Guo, Ye; Cao, Junning; Huang, Huiqiang; Wang, Zhao; Huang, Sha; Fang, Yiqian; Lyu, Jiaoyan; Zhang, Yiting; Liu, Yang; Zhou, Keshu; Zhang, Huilai
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 11, pp. 3897-3908. DOI: 10.1182/bloodadvances.2025018482
        PubMed      DOI
    8.Advances in the diagnosis and classification of B-ALL: comparative insights from updated guidelines

    Author: Chen, Xue; Yuan, Lili; Ma, Xiaoli; Wang, Fang; Zhang, Yang; Fang, Jiancheng; Cao, Panxiang; Wang, Tong; Chen, Jiaqi; Zhou, Xiaosu; Long, Jing; Liu, Hongxing
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 10, pp. 3640-3652. DOI: 10.1182/bloodadvances.2025017301
        PubMed      DOI
    9.Proteogenomic features define subtypes of mantle cell lymphoma

    Author: Yan, Yuting; Chen, Weihao; Jian, Xinzhou; Sun, Jian; Yu, Lei; Garcia-Mansfield, Krystine; Zhang, Xinyi; Yu, Ying; Xiong, Wenjie; Zou, Dehui; An, Gang; Jia, Zhenyu; Pirrotte, Patrick; Li, Jessica Jingyi; Yu, Zhen; Hao, Mu; Qiu, Lugui; Qi, Jianwei; Wang, Lili; Yi, Shuhua
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 10, pp. 3529-3540. DOI: 10.1182/bloodadvances.2025018701
        PubMed      DOI
    10.Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia

    Author: Gill, Harinder; Palandri, Francesca; Ross, David M.; Goethert, Joachim R.; Cochrane, Tara; Larsen, Stephen R.; Halpern, Anna B.; Shortt, Jake; Rossetti, James M.; Liang, James; Marchetti, Monia; Wilson, Andrew J.; Innes, Andrew J.; Hanna, Merit; Vianelli, Nicola; Stevenson, William S.; Vannucchi, Alessandro M.; Kleppe, Maria; Flynn, Jessica; Natsoulis, Georges; Harrison, Claire N.; Rienhoff Jr, Hugh Young
    Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 10, pp. 3494-3504. DOI: 10.1182/bloodadvances.2025017575
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    LANCET70092.40
    NATURE REVIEWS MICROBIOLOGY250124.00
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Nature Reviews Materials61110.60
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共1


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室